dr kgm hep b
TRANSCRIPT
Hepatitis B virus
Dr. K. G. MaharjanLiver unit, Bir hospital
Introduction• Hepatitis is an inflammation of the liver.• It is usually caused by viral & non viral infections also
due to toxins (alcohol) & drugs (mostly ATT) • In our setup it maybe due to bacterial infection but
may be an autoimmune response as well. • It is characterized by anorexia , jaundice, abdominal
pain, liver enlargement and sometimes fever.• Others , usually bacterial infections leading to HV&IVC
thrombophlebitis, metabolic cause (Wilson disease)• Congestive causes like ( HVOO,IVC disease , CHF)• HBV can lead to cirrhosis and liver cancer.
Introduction• Hepatitis is an inflammation of the liver.• It is usually caused by viral & non viral infections also
due to toxins (alcohol) & drugs (mostly ATT) • In our setup it maybe due to bacterial infection but
may be an autoimmune response as well. • It is characterized by anorexia , jaundice, abdominal
pain, liver enlargement and sometimes fever.• Others , usually bacterial infections leading to HV&IVC
thrombophlebitis, metabolic cause (Wilson disease)• Congestive causes like ( HVOO,IVC disease , CHF)• HBV can lead to cirrhosis and liver cancer.
Viral hepatitis
• The different types of viral hepatitis A,E,(virus transmitted through the faces of an infected person.
• Hepatitis B,C,D are serum hepatitis • Hepatitis F,G, cryptogenic ( caused by a virus
as not identified)• More hepatitis viruses are less common
yellow fever, epstien barr virus(EBV), cytomegalovirus(CMV),
Hepatitis B virus
• HBV is a serious disease ,can cause lifelong infection , liver cirrhosis ,liver cancer , and liver failure ,death.
• HBV is 100 times more infectious than HIV and 10 times more infectious than HCV.
• HBV is a blood borne transmitted ( body fluids , semen, saliva,vaginal fluid (high titers in the blood and lower titer in body fluids)
Hepatitis B virus introductions
• HBV is a 42 nm,double-shelled DNA virus of the class Hepadnaviridae.
• The outer surface membrane contains HBV surface antigen (HBsAg) which also circulates in blood as 22 nm spherical and tubular particles.
HBV virus
Continu…
• The inner core of the virus contains HBV core antigen (HBcAg) (HBeAg)
• HBV is a single molecule of partially double –stranded DNA, and DNA- dependent DNA polymerase.
Continu…
Risk groups • 1, I/V drug users Health workers • 2, Multiple sex partners• 3,Homosexuals• 4,Infant born to HBV infected mothers• 5,Hemodialysis patients• 6, Areas with high rates of HBV infections• 7,Tatooing
HBV transmitted
• HBV is transmitted by the exchange of blood & body fluids ,eg . Blood, semen, breast milk ,saliva and vaginal secretor fluids , tears.
Epidemiology
• Globally• 50 million new cases per year• 350-400 million chronic carriers 75% in Asia• 520,000 deaths per year
Epidemiology in Nepal
• One epidemiology study in done in nepal• Group;1, Population No. HBsAg • a, Soldiers 922 20 (2.2%)• b, healthy people 232 2 (0.8%)
from districts• c, pregnant women 81 1 (1.2%)• d, blood donors 624 5 (0.8%)• blood donors 168 1 (0.6%)
Continu…….• Group 2,• Hospital staff 792 7 (0.8%)• Student nurses 122 0• Relatives of CLD 388 12 (3.1%)• Patients• Group 3,• Hemophilia 4 1 (25%)• Drug addicts 72 2(3%)• Hemodialysis 41 1(2%)• HBV carriers 49 49(100%)
Continu…
• Group 4,• Chronic liver disease 145 57 (39%)• Acute hepatitis 150 14 (9.3%)
Clinical course of hepatitis B infection
Death Recovery
Acute hepatitis
Transient Subclinicalinfection
Acute HBV infection
25% 65%
Cirrhosis
Healthy HBsAgCarrier
Hepatocellular Carcinoma
Chronic Hepatitis
Chronic HBV Infection
1% 99%
100%
10-30% 70-90%10%
?
?
HBsAgConfirmation by neutralization
True PositiveALT
Raised Normal
NegativeSearch for other virus
HbcAbAnti-HbcIgM Positive
F/u after 6 monthsNegative
HBeAg
Positive Negative
Liver biopsyHBvDNA
Rx
HBcAbPositive
Liver biopsyHBvDNAAbsent Raised
HBvDNA
RxSearch for other causes of
ALT
Negative
Positive NegativeF/U
HBvDNA F/U
>105ml <105ml
F/URx
Infection
• Acute hepatitis B develops in approximately 30% to 50% of adults at the time of initial infection and is characterized by anorexia, nausea , vomiting and jaundice.
• SGPT raises 2 ½ times• The risk of progression to chronic infection varies with
age , being highest among young children and infants (30%-90%) and lowest among adolescents and adults (2%-6%).
• Rates of progression to cirrhosis and HCC vary according to age at acquisition of chronic infections ,HBeAg status , co infection with HGV,HIV,HCV, and alcohol abuse.
Clinical features
• The first serologic marker to appear following acute infection is HBsAg, which can be detected as early as 1 or 2 weeks and as late as 11 or 12 weeks (mode 30-60 days) after exposure to HBV
• HBeAg is generally detectable in patients with acute infections, the presence of HBeAg in serum correlates with higher titers of HBV and greater infectivity.
Continu….
• A diagnosis of acute HBV infection can be made on the basis of the detection of IgM class antibody to HBV core antigen (IgM ,anti-HBc) in serum ,It is generally detectable at the time of clinical onset.
Serological markers ; HBV
• HBsAg: Marker of infection,presence >6months=chronic
• HBeAg: active viral replication,• Anti-HBsAg: indicates recovery and /or
immunity (after vaccine)• Anti-Hbe: inactive viral replication• Anti-HBc: infection or immunity
HBV genotypes• HBV classified into 7 genotypes (A-G)• -a: north america and western europe• B&C: asia• D: southern europe and india• E:&G: africa• F:central and south america and alaska• H: central america• B associated with less HCC, less active and more slowly
progressive liver disease than C• A&B respond better to Interferon than C&D• Genotype does not predict response to oral agents
HBV infection
• Chronic HBV: chronic necroinflammatory liver disease >6month,ALT^,HBeAg-postive or –negative, HBV DNA> 10 x4-5
• Inactive HBsAg carrier : Persistent infection without necroinflammatory disease, ALT normal , HBeAg -negative HBV DNA<10 x 4-5
• Resolved HBV: previous infection without virological ,biochemicalor histological evidence of active disease.
Continu…
• Acute exacerbation HBV: elevated ALT>10 x ULN or >2 x baseline
• Reactivation of HBV: reappearance of necroinflammatory disease in person known to be inactive carrier or resolved HBV
Phases of chronic HBV• Immunotolerant phase: HBeAg- postive; HBV
DNA high (10 x 5-10) ALT normal -candidates for therapy.Immunoactive phase: HBeAg-postive or HBeAg –
negative,HBV DNA high (10 x4-10) ,ALT elevated, symptoms +/-
Non replicative phase :(inactive HBV carrier)HBeAg –negative HBV DNA low(<10 x4 ) ALT
normal, HBsAg may later become undectable.
Liver histology ≥
Routine HBV carriers exam
• Follow-up interval 6 months : Tests : ALT and AST; AFP. USG,
• Inactive HBsAg carrier: If ALT/AST increase , re evaluate
• Chronic hepatitis B: CBC,LFT,HBeAg, anti-HBe
HBV infected mothers
• Hepatitis B immunoglobulin (HBIG 0.5 ml , I/M to new born.
• Hepatitis B vaccination should have been given 12 hours of birth.
Post exposure prophylaxis
• 1, HBIG is required • 2,the first dose of hepatitis B vaccine
immediately, 0 – 1 – 6 months.
Hepatitis B vaccine
• The standard regimen for adult is 10-20mcg initially ( depending on the formulations ) .
• Schedules; 0 -1 -6 months.• Alternative schedules have been approved• 0 -1 -2 -12 months• 0- 7 and 21 days ,plus 12 months• Preferred site vaccine deltoid muscles
Treatment of chronic HBV• Nucleoside/nucleotide analogues: - Entecavir : 0.5-1.0 mg/d• -Lamivudine : 100 mg/d• -Adefovir dipivoxil :10mg/d• -Tenoforvir : 300mg/d• Interferon: interferon alfa-2b 5MU/d or 10MU tiw x 4
months.• Peginterferon alfa-2a (Pegasys) 180 mcg/week x 24-48
weeks.• Liver transplantation ( decompensated chronic HBV
with cirrhosis.
Reference
• Davidson principal and practice of medicine• C.M.D.T• Oxford hand book of medicine• Liver unit, Bir hospital
Thank you
Thank you